Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.
about
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotidesCorrection of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophyAntisense-mediated exon skipping: a versatile tool with therapeutic and research applicationsDynamics of co-transcriptional pre-mRNA folding influences the induction of dystrophin exon skipping by antisense oligonucleotides.Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal musclesBifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts.The potential of antisense as a CNS therapeutic.Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing.A prospective study in the rational design of efficient antisense oligonucleotides for exon skipping in the DMD gene.Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense.Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells.Telomerase - strategies to exploit an important chemotherapeutic target.A cationic morpholino antisense oligomer conjugate: synthesis, cellular uptake and inhibition of Gli1 in the hedgehog signalling pathway
P2860
Q24645148-E8688A42-B9C3-4904-B6E7-7F1B208F1068Q24679378-52013CC6-5856-442F-85D1-FE72F14E32B5Q24682555-8C45430A-F176-4EB6-9A88-07A663EEE4BBQ33325470-EDDCAFE3-F9D3-4618-8D51-C4C4C710E290Q33715654-02A42DA3-C217-4C2C-80B3-2CF4F57FFEB1Q34921907-14E76C5F-6BEF-47D3-83D4-C03544E68B6CQ35143897-3491ACA3-0F72-43A7-BF63-54D76CD20401Q35202466-B6D4A040-2B98-4917-A87B-795DB58B6E48Q35805025-92E85680-8032-437E-897A-8F50B94FFC89Q36114216-A1E9A434-C752-45A5-B244-77D62179DEC0Q41944520-473C3D8F-DF1A-472F-9852-FF4C428D5320Q44960581-DB1CAADD-ADF4-43F7-B27F-A5C0A18FE930Q52549011-121E20FA-3EC3-49C5-90A9-007FFC96E753Q57464951-11F2DEF4-D9BD-4DF1-9563-8D788E13124F
P2860
Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Modification of alternative sp ...... for cancer and other diseases.
@ast
Modification of alternative sp ...... for cancer and other diseases.
@en
Modification of alternative sp ...... for cancer and other diseases.
@nl
type
label
Modification of alternative sp ...... for cancer and other diseases.
@ast
Modification of alternative sp ...... for cancer and other diseases.
@en
Modification of alternative sp ...... for cancer and other diseases.
@nl
prefLabel
Modification of alternative sp ...... for cancer and other diseases.
@ast
Modification of alternative sp ...... for cancer and other diseases.
@en
Modification of alternative sp ...... for cancer and other diseases.
@nl
P2093
P356
P1476
Modification of alternative sp ...... for cancer and other diseases.
@en
P2093
P304
P356
10.2174/1568009013334124
P577
2001-11-01T00:00:00Z